Proteases
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 25149 | Safusidenib | 1898206-17-1 | ≧98.0% |  |
| Safusidenib, also known as DS-1001, is an oral isocitrate dehydrogenase [NADP] cytopl | ||||
| 25176 | AG-270 | 2201056-66-6 | ≧98.0% |  |
| MAT2A Inhibitor AG-270 is an orally available small molecule inhibitor of methionine | ||||
| 24101 | Crelosidenib | 2230263-60-0 | ≧98.0% |  |
| Crelosidenib is an isocitrate dehydrogenase 1 (IDH1) inhibitor. | ||||
| 24031 | GW-280264 ( GW-280264X ) | 866924-39-2 | ≧98.0% |  |
| GW-280264 ( GW-280264X ) is the mixedADAM10/TACE (ADAM17) metalloproteinasesinhibitor. | ||||
| 24108 | JHU-083 | 1998725-11-3 | ≧98.0% |  |
| JHU-083 selectively blocks glutaminase activity in brain CD11b+ cells and prevents de | ||||
| 24109 | CBR-5884 | 681159-27-3 | ≧98.0% |  |
| CBR 5884 is a phosphoglycerate dehydrogenase (PHGDH) inhibitor which was able to inhi | ||||
| 25147 | MAT2A-IN-9 ( GSK4362676 ) | 2439277-80-0 | ≧98.0% |  |
| MAT2A-IN-9 ( GSK4362676 ), is a 2-oxoquinazoline derivative, is a potent MAT2A (methi | ||||
| 25150 | Ranosidenib | 2301974-60-5 | ≧98.0% |  |
| Ranosidenib, also known as HMPL-306, is an isocitrate dehydrogenase (IDH) inhibitor. | ||||
| 25155 | PF-07853578 | 3036158-98-9 | ≧98.0% |  |
| PF-07853578 is a Patatin-Like Phospholipase Domain-Containing 3 Protein (PNPLA3) modu | ||||
| 25178 | DS-1001b | 1898207-64-1 | ≧98.0% |  |
| DS-1001 is an oral brain-penetrant mutant IDH1 selective inhibitor. | ||||